Filing Details

Accession Number:
0000899243-16-027015
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-08-12 18:08:37
Reporting Period:
2016-08-11
Filing Date:
2016-08-12
Accepted Time:
2016-08-12 18:08:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1103021 Biodelivery Sciences International Inc BDSI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1012794 B William Stone C/O Biodelivery Sciences Intl, Inc.,
4131 Parklake Avenue, Suite 225
Raleigh NC 27612
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-08-11 15,000 $0.00 122,675 No 4 M Direct
Common Stock Acquisiton 2016-08-11 17,500 $0.00 140,175 No 4 M Direct
Common Stock Disposition 2016-08-11 16,000 $2.57 124,175 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2016-08-11 15,000 $0.00 15,000 $0.00
Common Stock Restricted Stock Units Disposition 2016-08-11 17,500 $0.00 17,500 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-08-11 2016-08-11 No 4 M Direct
17,500 2016-08-11 No 4 M Direct
Footnotes
  1. The shares of common stock were acquired by the Reporting Person as a result of the vesting of 15,000 Restricted Stock Units ("RSUs") granted to the Reporting Person on July 16, 2015 under the Issuer's 2011 Equity Incentive Plan, as amended.
  2. The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-half of the RSUs granted to the Reporting Person on June 30, 2016 under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining RSUs under this grant will vest in the first open window following the Company's 2017 Annual Meeting of Stockholders.
  3. The shares of common stock were sold to cover the Reporting Person's tax liability upon the vesting of RSUs.
  4. On August 11, 2016, the Reporting Person sold an aggregate of 16,000 shares of the Issuer's Common Stock at a weighted average price of $2.57. The highest sale price for the Common Stock was $2.72 per share and the lowest sale price was $2.47 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.